Home
Data
Calendar
Blog
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Common Stock Value | 0.00 | 0.00 | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 15.47 | 14.81 | 11.79 | 10.91 | |
| Weighted Average Number Of Shares Outstanding Basic | 15.47 | 14.62 | 11.79 | 10.91 | |
| Earnings Per Share Basic | -2.84 | 127.10 | -4.39 | -4.31 | |
| Earnings Per Share Diluted | -2.84 | 125.48 | -4.39 | -4.31 |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Revenues | 0.00 | 0.10 | 0.12 | 0.03 | |
| Operating Expenses | 46.80 | 161.00 | 45.95 | 41.37 | |
| Research And Development Expense | 38.89 | 67.63 | 38.06 | 34.11 | |
| General And Administrative Expense | 7.90 | 93.37 | 7.89 | 7.26 | |
| Operating Income Loss | -46.80 | -160.90 | -45.83 | -41.34 | |
| Income Tax Expense Benefit | 0.00 | 0.00 | 0.00 | 0.01 | |
| Net Income Loss | -43.86 | 1858.01 | -51.79 | -47.05 |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Assets | 222.56 | 258.42 | NA | NA | |
| Liabilities | 44.09 | 39.05 | NA | NA | |
| Liabilities And Stockholders Equity | 222.56 | 258.42 | NA | NA | |
| Stockholders Equity | 178.47 | 219.37 | 129.59 | -24.81 |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Assets Current | 207.45 | 242.06 | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 196.33 | 226.86 | NA | NA | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 196.33 | 226.86 | 337.33 | 192.49 | |
| Other Assets Current | 0.75 | 0.97 | NA | NA | |
| Prepaid Expense And Other Assets Current | 9.99 | 13.81 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 15.10 | 15.08 | NA | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 8.22 | 7.48 | NA | NA | |
| Property Plant And Equipment Net | 6.88 | 7.61 | NA | NA | |
| Other Assets Noncurrent | 6.71 | 6.75 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Liabilities Current | 44.09 | 39.05 | NA | NA | |
| Accounts Payable Current | 12.37 | 13.02 | NA | NA | |
| Other Accrued Liabilities Current | 0.36 | 0.42 | NA | NA | |
| Accrued Liabilities Current | 29.89 | 23.86 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Stockholders Equity | 178.47 | 219.37 | 129.59 | -24.81 | |
| Common Stock Value | 0.00 | 0.00 | NA | NA | |
| Additional Paid In Capital | 236.73 | 233.77 | NA | NA | |
| Retained Earnings Accumulated Deficit | -58.27 | -14.40 | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2.96 | 46.17 | 6.53 | 6.25 |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -30.28 | NA | -54.24 | NA | |
| Net Cash Provided By Used In Investing Activities | -0.25 | NA | -0.81 | NA | |
| Net Cash Provided By Used In Financing Activities | 0.00 | NA | 199.89 | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -30.28 | NA | -54.24 | NA | |
| Net Income Loss | -43.86 | 1858.01 | -51.79 | -47.05 | |
| Depreciation Depletion And Amortization | 0.76 | 0.47 | 0.30 | 0.29 | |
| Increase Decrease In Accounts Receivable | -0.42 | NA | 0.00 | NA | |
| Increase Decrease In Accounts Payable | -0.45 | NA | -1.59 | NA | |
| Share Based Compensation | 2.96 | NA | 6.53 | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | -0.25 | NA | -0.81 | NA | |
| Payments To Acquire Property Plant And Equipment | 0.25 | NA | 0.81 | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 0.00 | NA | 199.89 | NA |
| 2024-09-30 | 2024-06-30 | 2023-09-30 | 2023-06-30 | ||
|---|---|---|---|---|---|
| Revenues | 0.00 | 0.10 | 0.12 | 0.03 | |
| A2seventy Bio Inc, License Non Affiliate | 0.00 | 0.10 | NA | NA | |
| Regeneron Pharmaceuticals Inc., License Non Affiliate | 0.00 | 0.10 | NA | NA | |
| License Non Affiliate | 0.00 | 0.10 | 0.12 | 0.03 | |
| License | 0.00 | 0.10 | 0.12 | 0.03 |
